DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sangam (India) Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·31 Aug 2026, 9:24 am

Sangam (India)

Sangam (India) Limited has informed the stock exchanges about the schedule for its upcoming institutional investor meet. This announcement signals the company's intent to engage directly with financial analysts and large investors to discuss its business strategy and future outlook.

For investors, this event is significant as it provides an opportunity to gain clarity on the company's direction. The management will likely address recent performance and share their vision for the sector, helping retail investors make more informed decisions based on direct communication.

Investors should watch for updates regarding the company's guidance on sales, margins, and capital expenditure during the interaction. Following the event, any key takeaways or specific comments from management will be crucial for assessing the stock's short-term momentum.